ciltacabtagene autoleucel (cilta-cel)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ciltacabtagene autoleucel (cilta-cel), covering 2026-06-05 to 2026-06-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) Followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA Versus VRd Followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants With Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy [Phase 3]